Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD ... to be a major adverse event after the implantation of the device ...

Under these circumstances, the indication of a short- or long-term device will rely on timing of implantation (urgent or emergent), patient characteristics and physician criteria.

SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...

The findings suggest that changes of OxPhos proteins in white blood cells could help predict new strokes after cardiac assist device implantation.

The most common type of VAD is a left ventricular assist device (LVAD) used to support the heart's left ventricle function.

Called left ventricular assist devices (LVADs), they help circulate ... as well as all over the world, the implantation of LVADs is growing rapidly," he said. The survival of patients on ...

The Texas Heart Institute (THI) and BiVACOR, a clinical-stage medical device company ... or univentricular heart failure in ...

Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit ...

The BiVACOR Total Artificial Heart, a device currently undergoing clinical trials, was used in August to keep Donavan Harbison, a resident of Graham, N.C., alive for 10 days while he awaited a heart ...

The program helps patients with end-stage heart failure get left ventricular assist devices, commonly known as LVADs. The mechanical pump is surgically implanted and is often used as a bridge for ...

The device provides an option for eligible patients with severe biventricular heart failure or univentricular heart failure in which left ventricular assist device support ... second in the world ...

Ventricular assist devices are mechanical pumps ... and can support the right, left or both ventricles. Devices are implanted through a median sternotomy; in a LVAD, the inflow cannula is ...